Scholarlink

Objective <p>To evaluate the clinical efficacy and safety of a minimally invasive endoscopic protocol—combining curettage, sclerotherapy, and injectable bone grafting—in the treatment of unicameral bone cysts (UBCs).</p> Methods <p>From March 2019 to August 2024, 33 pediatric and adolescent patients with UBCs were treated using a standardized minimally invasive endoscopic curettage combined with sclerotherapy and injectable bone grafting at our institution. The cohort included 24 males and 9 females, with a mean age of 10.1&#xa0;years (range 4–20&#xa0;years). Patients were followed for an average of 48.4&#xa0;months (range 12–76&#xa0;months). Radiographic healing rates, functional score, and complications were assessed.</p> Results <p>According to the modified Neer classification, complete or partial radiographic healing was achieved in 30 cases (90.9%), while 3 cases experienced persistent or recurrent cyst (9.1%). Almost all patients recovered excellent function. No postoperative pathological fractures or growth plate disturbances were observed during a mean follow-up of 48.4&#xa0;months. Complications were limited to one episode of transient pain and one case of mild swelling, both self-limiting without intervention. Postoperative hospitalization was brief (mean, 1.2&#xa0;days), and cosmetic outcomes were excellent, with minimal portal scars, far less conspicuous than those from traditional open procedures.</p> Conclusion <p>Endoscopic minimally invasive surgery combining curettage, sclerotherapy, and injectable bone grafting appears to be a safe and effective option for the management of UBCs in children and adolescents, achieving high healing rates and low complication risks. Nevertheless, given the single-arm design and limited sample size, larger controlled studies with long-term follow-up are needed to confirm these findings.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Minimally invasive endoscopic treatment for unicameral bone cysts: technique and outcomes in a series of 33 pediatric and adolescent patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月18日

查看全文
  • Lenian Zhou,
  • Zengxin Jiang,
  • Zeng Zhang,
  • Qingcheng Yang,
  • Ting Yuan

摘要

Objective

To evaluate the clinical efficacy and safety of a minimally invasive endoscopic protocol—combining curettage, sclerotherapy, and injectable bone grafting—in the treatment of unicameral bone cysts (UBCs).

Methods

From March 2019 to August 2024, 33 pediatric and adolescent patients with UBCs were treated using a standardized minimally invasive endoscopic curettage combined with sclerotherapy and injectable bone grafting at our institution. The cohort included 24 males and 9 females, with a mean age of 10.1 years (range 4–20 years). Patients were followed for an average of 48.4 months (range 12–76 months). Radiographic healing rates, functional score, and complications were assessed.

Results

According to the modified Neer classification, complete or partial radiographic healing was achieved in 30 cases (90.9%), while 3 cases experienced persistent or recurrent cyst (9.1%). Almost all patients recovered excellent function. No postoperative pathological fractures or growth plate disturbances were observed during a mean follow-up of 48.4 months. Complications were limited to one episode of transient pain and one case of mild swelling, both self-limiting without intervention. Postoperative hospitalization was brief (mean, 1.2 days), and cosmetic outcomes were excellent, with minimal portal scars, far less conspicuous than those from traditional open procedures.

Conclusion

Endoscopic minimally invasive surgery combining curettage, sclerotherapy, and injectable bone grafting appears to be a safe and effective option for the management of UBCs in children and adolescents, achieving high healing rates and low complication risks. Nevertheless, given the single-arm design and limited sample size, larger controlled studies with long-term follow-up are needed to confirm these findings.